Risk and Benefit of Oral Anticoagulants in Atrial Fibrillation

被引：0
|
作者：
Zotova, I. V. [1 ]
Zateyshchikov, D. A. [1 ]
机构：
[1] President RF, FSI Educ Sci Med Ctr, Gen Management Dept, Moscow 121356, Russia
来源：
KARDIOLOGIYA | 2011年 / 51卷 / 10期
关键词：
atrial fibrillation; indirect anticoagulants; thromboembolism; bleeding; risk stratification; CLINICAL CLASSIFICATION SCHEMES; MAJOR BLEEDING COMPLICATIONS; SOLUBLE CD40 LIGAND; WARFARIN THERAPY; STROKE RISK; VENOUS THROMBOEMBOLISM; ARTERIAL EMBOLISM; NATIONAL REGISTRY; PREDICTING STROKE; ISCHEMIC-STROKE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Thromboembolism is the main cause of death and disability of patients with atrial fibrillation. Indirect anticoagulants are effective means of primary and secondary prevention of thromboembolic complications. However in a number of patients risk associated with therapy with indirect anticoagulants might exceed potential benefit. The principle problem requiring solution in a patient with atrial fibrillation is individual comparative assessment of risk of development of thromboembolic and hemorrhagic complications. Modern stratification scales which allow solving this problem are considered in this review.
引用
收藏
页码：81 / 91
页数：11
相关论文
共 50 条
  • [31] Oral anticoagulants in older adults with atrial fibrillation
    Bernacki, Gwen M.
    Becker, Richard C.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 36 (04) : 403 - 415
  • [32] New oral anticoagulants in atrial fibrillation: are they comparable?
    Kalodiki, E.
    Lewis, B.
    Fareed, J.
    [J]. INTERNATIONAL ANGIOLOGY, 2012, 31 (04) : 307 - 309
  • [33] Oral anticoagulants for Asian patients with atrial fibrillation
    Ian Sabir
    Kaivan Khavandi
    Jack Brownrigg
    A. John Camm
    [J]. Nature Reviews Cardiology, 2014, 11 : 290 - 303
  • [34] Adherence to oral anticoagulants in patients with atrial fibrillation
    Grimaldi-Bensouda, Lamiae
    Le Heuzey, Jean-Yves
    Abenhaim, Lucien
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 106 - 106
  • [35] New oral anticoagulants in nonvalvular atrial fibrillation
    Lega, Jean-Christophe
    Bertoletti, Laurent
    Durupt, Stephane
    Epinat, Magali
    Mismetti, Patrick
    Da Costa, Antoine
    Laporte, Silvy
    [J]. PRESSE MEDICALE, 2013, 42 (09): : 1225 - 1231
  • [36] New Oral Anticoagulants in Nonvalvular Atrial Fibrillation
    Urooj, Fatima
    Kulkarni, Abhishek
    Stapleton, Dwight
    Kaluski, Edo
    [J]. CLINICAL CARDIOLOGY, 2016, 39 (02) : 739 - 746
  • [37] New oral anticoagulants in patients with atrial fibrillation
    Desborough, Michael J. R.
    Jairath, Vipul
    [J]. LANCET, 2014, 384 (9937): : 24 - 24
  • [38] Net benefit of oral anticoagulants in patients with atrial fibrillation and active cancer: a nationwide cohort study
    Atterman, Adriano
    Friberg, Leif
    Asplund, Kjell
    Engdahl, Johan
    [J]. EUROPACE, 2020, 22 (01): : 58 - 65
  • [39] Reduced risk of dementia among patients with atrial fibrillation receiving oral anticoagulants
    Sposato, Luciano A.
    Chen, Lin Y.
    [J]. NEUROLOGY, 2018, 91 (19) : 857 - 858
  • [40] Comparing the risk of dementia in patients with atrial fibrillation taking different oral anticoagulants
    Sung, Sheng-Feng
    Yang, Hsin-Yi
    Tsai, Ching-Fang
    Fang, Chen- Wen
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 139 - 141
12345